1)Sternberg CN, Yagota A, Scher HI, et al:M-VAC(Methotrexate, Vinblastine, Doxorubicin and Cisplatin)for advanced transitional cell carcinoma of the urothelium. J Urol 133:403-407, 1985
2)Saxman SB, Propert KJ, Einhorn LH, et al:Long-term follow up of a phaseⅢintergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma:A cooperative group study. J Clin Oncol 16:2564-2569, 1997
3)Loehrer PJ, Einhorn LH, Elson PJ, et al:A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicine in patients with metastatic urotherial carcinoma:a cooperative group study. J Clin Oncol 10:1066-1073, 1992
4)Skinner DG, Daniels JR, Russell CA, et al:The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer:a prospective comparative trial. J Urol 145:459-464, 1991
5)Freiha F, Reese J, Torti FM:A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155:495-499, 1996
6)Stockle M, Wellwk S, Meyenburg W, et al:Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder:prognostic impact of lymph node involvement. Urology 48:868-875, 1996
7)Sternberg CN, de Mulder PHM, Schonagel JH, et al:Randomized phaseⅢtrial of high-dose-intensity methotrexate, vinblastine, doxorubicin and cisplatin(MVAC)chemotherapy and recombinant human glanulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors:European organization for research and treatment of cancer protocol No. 30924. J Clin Oncol 19:2638-2646, 2001
8)Hussain M, Vaishampayan U, Du W, et al:Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer. J Clin Oncol 19:2527-2533, 2001
9)Bellumunt J, Guillem V, Paz-Ares L, et al:PhaseⅠ-Ⅱstudy of paclitaxel, cisplatin, and gemcitabine in advanced transitional cell carcinoma of the urothelium. J Clin Oncol 18:3247-3255, 2000
10)Pectasides D, Glotsos J, Bountouroglou N, et al:Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer:a phaseⅡtrial. Ann Oncol 13:243-250, 2002
11)von der Maase H, Hansen SW, Roberts JT, et al:Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer:results of a large, randomized, multinational, multicentre, phaseⅢstudy. J Clin Oncol 17:3068-3077, 2000
12)Hoshi S, Ohyama C, Ono K, et al:Gemcitabine plus carboplatin, and gemcitabine, docetaxel and carboplatin combined chemotherapy regimens in patients with metastatic urothelial carcinoma previously treated with a platinum-based regimen. Int J Clin Oncol 9:125-129, 2004
13)Moon C, Verschraegen CF, Bevers M, et al:Use of docetaxel(Taxotare)in patients with paclitaxel(Taxol)hypersensitivity. Anticancer Drugs 11:565-568, 2000